FIELD: medicine, ophthalmology.
SUBSTANCE: agent can be used for treatment of myopathy, retinopathy, for ophthalmic discomfort and fatigue relief, for prophylaxis and treatment of retina detachment of different etiology, among them, for prophylaxis of retina detachment in surgery. Agent comprises acid glycoprotein isolated from mammalian retina, calcium chloride and a carrier. Invention provides the absence of adverse effects and allergic responses and intolerability of preparation.
EFFECT: improved treatment method, valuable medicinal properties of agent.
22 cl, 1 tbl, 8 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR PREPARING MEDICINAL AGENT FOR TREATMENT OF EYE RETINA DISEASES | 2005 |
|
RU2311914C2 |
| METHOD FOR PREPARING MEDICINAL AGENT FOR TREATMENT OF EYE RETINA AND PIGMENT EPITHELIUM AND EYE VASCULAR ENVELOPE | 2005 |
|
RU2311915C2 |
| AGENT RECOVERING RETINA EYE FUNCTION | 1993 |
|
RU2073518C1 |
| TETRAPEPTIDE STIMULATING EYE RETINA FUNCTION, PHARMACOLOGICAL AGENT BASED ON THEREOF AND METHOD OF ITS USING | 2000 |
|
RU2161982C1 |
| METHOD FOR TREATING DYSTROPHIC DISEASES OF EYES | 2000 |
|
RU2195297C2 |
| COMBINED OPHTHALMIC AGENT | 2019 |
|
RU2733392C1 |
| PROTEIN-PEPTIDE COMPLEX HAVING A PROTECTIVE ACTION ON THE STATE OF TISSUES OF THE POSTERIOR EYE - SCLERAL SHELL, RETINA, PIGMENT EPITHELIUM, CHOROID | 2018 |
|
RU2701566C1 |
| OPHTHALMOLOGICAL MEDICINAL PREPARATION AND METHOD FOR TREATING DISEASES AND DISORDERS OF CORNEA | 2001 |
|
RU2220687C2 |
| METHOD FOR PREPARING MEDICINAL AGENT FOR TREATMENT OF MYOPIA AND EYE SCLERAL ENVELOPE DISEASES AND VITREORETONOPATHY | 2005 |
|
RU2315606C2 |
| APPLICATION OF ANTAGONIST VEGF IN TREATMENT OF CHORIORETINAL NEOVASCULAR DISTURBANCES AND DISORDERS OF PENETRATION IN PEDIATRIC PATIENTS | 2014 |
|
RU2676274C2 |
